Differential expression of syndecans and glypicans in chronically inflamed synovium
2008

Differential Expression of Syndecans and Glypicans in Arthritis

Sample size: 46 publication Evidence: moderate

Author Information

Author(s): Patterson A M, Cartwright A, David G, Fitzgerald O, Bresnihan B, Ashton B A, Middleton J

Primary Institution: Arthritis Research Centre, Institute for Science and Technology in Medicine, Medical School, Keele University at Robert Jones and Agnes Hunt Orthopaedic Hospital, Oswestry, Shropshire, UK

Hypothesis

To investigate which heparan sulphate proteoglycans (HSPGs) are expressed in knee joint synovia from patients with different forms of arthritis and normal individuals.

Conclusion

The study found that selected HSPGs, such as syndecan-1, -2, and -3 and glypican-4, are differentially expressed in the synovium of patients with rheumatoid arthritis and psoriatic arthritis compared to osteoarthritis and normal synovia.

Supporting Evidence

  • Syndecan-1 was present in the mononuclear infiltrates of synovia from patients with rheumatoid and psoriatic arthritis.
  • Syndecan-2 was mainly found in blood vessels, while syndecan-3 was abundant in endothelial cells.
  • Glypican-4 was present in the lining layer and blood vessels of the synovium.
  • Increased expression of HSPGs was noted in rheumatoid and psoriatic arthritis compared to osteoarthritis and normal synovia.

Takeaway

This study looked at different proteins in the knees of people with arthritis and found that some proteins are more common in those with rheumatoid arthritis and psoriatic arthritis than in those with osteoarthritis or healthy knees.

Methodology

Synovial samples were obtained from patients with various forms of arthritis and normal individuals, and the expression of specific HSPGs was analyzed using immunohistochemistry and dual label immunofluorescence.

Limitations

The study may not account for all variables affecting HSPG expression in synovial tissues.

Participant Demographics

Included patients with early rheumatoid arthritis (n=8), longstanding rheumatoid arthritis (n=13), psoriatic arthritis (n=7), osteoarthritis (n=6), and normal joints (n=12).

Digital Object Identifier (DOI)

10.1136/ard.2006.063875

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication